1. Home
  2. VALN vs AEF Comparison

VALN vs AEF Comparison

Compare VALN & AEF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VALN
  • AEF
  • Stock Information
  • Founded
  • VALN 2012
  • AEF 1989
  • Country
  • VALN France
  • AEF United States
  • Employees
  • VALN N/A
  • AEF N/A
  • Industry
  • VALN Biotechnology: Biological Products (No Diagnostic Substances)
  • AEF Finance/Investors Services
  • Sector
  • VALN Health Care
  • AEF Finance
  • Exchange
  • VALN Nasdaq
  • AEF Nasdaq
  • Market Cap
  • VALN 332.0M
  • AEF 268.0M
  • IPO Year
  • VALN 2021
  • AEF N/A
  • Fundamental
  • Price
  • VALN $3.76
  • AEF $5.31
  • Analyst Decision
  • VALN Strong Buy
  • AEF
  • Analyst Count
  • VALN 2
  • AEF 0
  • Target Price
  • VALN $18.50
  • AEF N/A
  • AVG Volume (30 Days)
  • VALN 30.5K
  • AEF 92.5K
  • Earning Date
  • VALN 11-07-2024
  • AEF 01-01-0001
  • Dividend Yield
  • VALN N/A
  • AEF 7.13%
  • EPS Growth
  • VALN N/A
  • AEF N/A
  • EPS
  • VALN N/A
  • AEF 0.57
  • Revenue
  • VALN $176,817,979.00
  • AEF N/A
  • Revenue This Year
  • VALN $24.30
  • AEF N/A
  • Revenue Next Year
  • VALN $16.05
  • AEF N/A
  • P/E Ratio
  • VALN N/A
  • AEF $8.86
  • Revenue Growth
  • VALN N/A
  • AEF N/A
  • 52 Week Low
  • VALN $3.65
  • AEF $4.40
  • 52 Week High
  • VALN $10.76
  • AEF $5.53
  • Technical
  • Relative Strength Index (RSI)
  • VALN 37.11
  • AEF 53.46
  • Support Level
  • VALN $3.62
  • AEF $5.38
  • Resistance Level
  • VALN $4.09
  • AEF $5.54
  • Average True Range (ATR)
  • VALN 0.20
  • AEF 0.06
  • MACD
  • VALN 0.03
  • AEF 0.02
  • Stochastic Oscillator
  • VALN 39.44
  • AEF 63.89

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates the majority of its revenue from product sales.

About AEF abrdn Emerging Markets Equity Income Fund Inc.

ABERDEEN EMERGING MARKETS EQUITY INCOME FUND, INC. is a closed-end investment company. The Fund's investment objective is to seek to provide both current income and long-term capital appreciation. It invests in the public equity and fixed income markets of Chile. The Fund invests in a range of sectors, including financials, consumer staples, utilities, consumer discretionary, materials, energy, information technology, Private Equity, telecommunication services, healthcare, real estate and industrials.

Share on Social Networks: